Kawasaki Disease Clinical Trials

A listing of Kawasaki Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 47 clinical trials
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

children with Kawasaki disease (KD) .

immune globulin
immunoglobulin
aspirin
fever
igiv
  • 0 views
  • 20 Mar, 2021
  • 15 locations
Defibrotide in Children With High Risk Kawasaki Disease

This study evaluates the safety of defibrotide with IVIG in children with high risk Kawasaki disease.

  • 0 views
  • 10 Mar, 2021
  • 1 location
Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease

Kawasaki disease (KD) is the leading cause of acquired heart disease in children in the developed world. Despite available treatment, 25% of children in San Diego County appropriately treated

  • 0 views
  • 17 Feb, 2021
  • 1 location
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease

In this study, the investigator plan to prescribe Methylprednisolone pulse therapy in Kawasaki disease patients with coronary artery lesions or aneurysm formation beyond acute stage to

methylprednisolone pulse therapy
coronary artery aneurysm
vasculitis
igiv
aneurysm
  • 25 views
  • 25 Jan, 2021
  • 1 location
Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children

In children with Covid-19, the diagnosis of Kawasaki Disease (KD) and pneumonia should be made very quickly. However, the regional hospitals surrounding Paris don't have the required expertise

  • 0 views
  • 30 May, 2021
  • 2 locations
Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

genotype 1-4 co-infected with HIV-HCV, treated with Peginterferón alfa-2a (40 KD) 180 µg/week and Ribavirin (2000 mg/day during 4 weeks, follow of 1000-1200 mg/day, according to body weight

ribavirin
HIV Infection
peginterferon
chronic hepatitis
ribonucleic acid
  • 10 views
  • 07 Nov, 2020
  • 38 locations
Contribution of the Pharmacological Profile of the A2A Receptor to Adenosine in the Diagnosis of Myocardial Ischemia

The chronic coronary artery disease could be detected by a drop in the expression of A2A receptors to adenosine, while high values of the KD / EC50 ratio are a sign of coronary ischemia. Knowing

  • 0 views
  • 05 Jun, 2021
  • 1 location
Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

To characterize safety associated with the use of Kyprolis under the locally approved label.

  • 0 views
  • 19 Jun, 2021
  • 24 locations
Evaluation of the Modified Atkins Diet in Children With Epileptic Spasms

Epileptic spasms are a difficult to treat epileptic condition in young children. The first line treatment is hormonal treatment, in the form of ACTH or oral steroids, which are effective in 60-70% of children. The condition does not respond well to other anti-epileptic drugs except vigabatrin which is not approved …

  • 0 views
  • 22 Jan, 2021
  • 1 location
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

) of daratumumab subcutaneous (Dara-SC) in combination with carfilzomib and dexamethasone (Kd) with the efficacy of Kd in participants with relapsed refractory multiple myeloma who were previously

cell transplantation
dexamethasone
bisphosphonate
carfilzomib
progressive disease
  • 21 views
  • 22 Jul, 2021
  • 163 locations